Impilo is a Nordic-based private equity firm focused on healthcare and health-related industries in the Nordic region. It targets buyouts and growth investments in companies operating in pharmaceuticals, medical technology, medical devices, healthcare services, care services, and preventative care. The firm prefers majority stakes but may consider minority investments, and tends to invest in unlisted companies, while retaining the option to invest in publicly listed entities with a controlling position. Based in Stockholm with an additional office in Copenhagen, Impilo supports portfolio companies to drive sustainable development in their communities and markets.
Co-Founder, Partner, CFO and Investment Committee Member
Martin Fagerlund
Partner and COO
Andreas Hiller
Industrial Partner
Hans-Christian Bødker Jensen
Co-Founder, Partner and Investment Committee Member
Sören Mellstig
Co-Founder, Industrial Partner and Chairman
Victor Steien
Partner
Fredrik Strömholm
Co-Founder, Partner and Chairman of the Investment Committee
Henning Søgaard
Industrial Partner
Frederik Zimmer
Industrial Partner
Past deals in Denmark
Scantox
Acquisition in 2021
Scantox is a contract research organization located in Lille Skensved, Denmark, specializing in pharmacology and regulatory toxicology services. The company provides preclinical research services tailored for the pharmaceutical and medical device industries, assisting clients in advancing their drug or device development with reliable data that meets technical and scientific standards. Scantox offers a range of services, including safety pharmacology, exploratory testing, and endotoxin testing, ensuring comprehensive support throughout the product development process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.